Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

FDA Lowers Recommended Levels of Lead In Baby Food: Here’s What That Means

Por: Forbes Business January 25, 2023

thumbnail

Topline As part of their program removing lead, arsenic, mercury and cadmium from children’s diets, the FDA released new Tuesday further limiting lead concentration in processed baby food, estimated to reduce some kids’ dietary lead exposure by between 24% and 27%—though it’s unclear exactly what a safe level of lead consumption actually is for children. Gerber brand baby food at a Shoprite Supermarket. (Photo by James Leynse/Corbis via... + full article



Similar News

New FDA guidelines call for reducing — but not eliminating — lead in baby food

CBS News USA Politics January 25, 2023

thumbnailThe Food and Drug Administration released Tuesday that detail the maximum amount of lead that can be found in baby food products, and is part of the organization's initiative aiming to reduce childhood exposure to harmful contaminants in food.  The proposed action levels... + más

Panel warns FDA’s beleaguered tobacco unit lacks direction | Associated Press

Panel warns FDA’s beleaguered tobacco unit lacks direction | ABC News


House Dems raise issues with ‘atypical’ FDA review process for Alzheimer’s drug

Politico USA Health December 30, 2022

thumbnailThe FDA’s collaboration with Biogen, the maker of a controversial Alzheimer’s drug, before it granted the product accelerated approval was “atypical” and ran afoul of the agency’s protocol for documenting interactions with drug companies, according to a joint House... + más

Alzheimer's drug approval by FDA 'rife with irregularities,' probe finds | Los Angeles Times

Probe: Alzheimer's drug approval 'rife with irregularities' | ABC News


Alzheimer's drug approval by FDA 'rife with irregularities,' probe finds

Los Angeles Times USA Science December 30, 2022

thumbnailThe Food and Drug Administration’s contentious approval of a questionable Alzheimer’s drug took another hit Thursday as congressional investigators called the process “rife with irregularities.” The 18-month investigation by two House committees detailed “atypical... + más

Probe: Alzheimer's drug approval 'rife with irregularities' | ABC News

Probe: Alzheimer's drug approval 'rife with irregularities' | WPLG Local 10


FDA Approval of Alzheimer's Drug Was 'Rife With Irregularities': Congressional Report

NBC 6 South Florida USA World December 30, 2022

thumbnailAdam Glanzman Bloomberg Getty Images The ’s contentious approval of a questionable Alzheimer’s drug took another hit Thursday as congressional investigators called the process “rife with irregularities.” The 18-month investigation by two House committees detailed... + más

Alzheimer's drug approval by FDA 'rife with irregularities,' probe finds | Los Angeles Times

FDA approves Alzheimer's drug that slowed cognitive decline in clinical trial | CNBC


Panel warns FDA’s beleaguered tobacco unit lacks direction

ABC News USA Health December 20, 2022

thumbnailWASHINGTON -- The lack of clear direction and priorities at the U.S. Food and Drug Administration's tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más

Panel warns FDA’s beleaguered tobacco unit lacks direction | Associated Press

Panel warns FDA’s beleaguered tobacco unit lacks direction | WPLG Local 10


Panel warns FDA’s beleaguered tobacco unit lacks direction

WPLG Local 10 USA Politics December 20, 2022

thumbnailWASHINGTON – The lack of clear direction and priorities at the U.S. Food and Drug Administration's tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más

Panel warns FDA’s beleaguered tobacco unit lacks direction | ABC News

Panel warns FDA’s beleaguered tobacco unit lacks direction | Associated Press


Panel warns FDA’s beleaguered tobacco unit lacks direction

Associated Press USA Politics December 19, 2022

thumbnailWASHINGTON (AP) — The lack of clear direction and priorities at the U.S. Food and Drug Administration’s tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más

Panel warns FDA’s beleaguered tobacco unit lacks direction | ABC News

Panel warns FDA’s beleaguered tobacco unit lacks direction | WPLG Local 10



About iurex | Privacy Policy | Disclaimer |